Resource Logo
AIDS Treatment Data Network

(ATDN) Treatment Briefs: Growth Hormone Approved


Treatment Review No. 23 - December 1996

A new treatment for HIV-related wasting has been approved for prescription. Human Growth Hormone (trade name Serostim) has been shown to improve lean body mass in early studies, when given for a 12 week period. Lean body mass is a measurement of important muscle tissue where energy is stored. People with wasting seem to lose this tissue rather than fat, and loss of lean body mass can be fatal. The US Food and Drug Administration (FDA) has requested that the company that makes Serostim conduct further studies to work out how best to use this drug, as not all studies using Serostim have shown clear benefits. Serostim is very expensive, and can cost up to $36,000 a year. Serostim is given by an injection under the skin. The company that makes the drug, Serono Laboratories, has set up a patient assistance program that can be reached at (800) 714-2437.


Copyright © 1996 -AIDS Treatment Data Network, Publisher. All rights reserved to AIDS Treatment Data Network. Reproduction of this article (other than one copy for personal reference) must be cleared through the AIDS Treatment Data Network. Email AIDS Treatment Data Network

Information in this article was accurate in December 1, 1996. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.